There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 3 | 36 | 1734.2 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Annual Revenue,rose 8.73%, in the last year to ₹9,820.78 Cr. Its sector's average revenue growth for the last fiscal year was 12.13%.Annual Net Profit,rose 54.69% in the last year to ₹1,141.12 Cr. Its sector's average net profit growth for the last fiscal year was 1.9%.Price to Earning Ratio,is 39.24, lower than its sector PE ratio of 44.99.
IPCA Laboratories Limited incorporated in the year 1949, is integrated pharmaceutical company manufacturing and marketing various formulations and many API’s covering various therapeutic segments. The products of the company are sold in many countries across the globe. The company has numerous manufacturing units in India manufacturing API’s and formulations for the world market.
The company is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India.
The intraday high for Ipca Laboratories Ltd on the NSE today (06 Aug 2026) was ₹1,785.00. This compares to the 52-week high of ₹1,944.90 recorded on 17 Jul 2026. Today's high was -8.22% below the 52-week high.
For Q4 FY26, Ipca Laboratories Ltd reported: Revenue (Net Sales): ₹18143.50 Cr - Down -1.67% year-on-year from ₹18451.80 Cr in Q3 FY26. Net Income (PAT): ₹2622.90 Cr - Down -13.56% year-on-year from ₹3034.50 Cr in Q3 FY26.
As of 06 Aug 2026, the share price of Ipca Laboratories Ltd is ₹1,740.30 on the NSE and ₹1,729.80 on the BSE. The stock opened at ₹1,775.00, touched a high of ₹1,785.00 and a low of ₹1,682.50 during today's session.
Over the last 6 months, Ipca Laboratories Ltd has given a return of 24.59%. The stock was priced at ₹1,416.70 on 06 Feb 2026 and has Rise to ₹1,740.30 as of 06 Aug 2026, a change of ₹323.60 per share.
Ipca Laboratories Ltd has delivered 27.23% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,944.90 on 17 Jul 2026 and a 52-week low of ₹1,251.60 on 24 Oct 2025. It is currently trading at ₹1,740.30 as of 06 Aug 2026.
The all-time high (ATH) for Ipca Laboratories Ltd was ₹1,900.60, recorded on 17 Jul 2026. At the current price of ₹1,740.30, the stock is trading 8.43% below its all-time high. The all-time low recorded was ₹104.60 on 07 Jan 2010.
Ipca Laboratories Ltd has delivered a 62.57% absolute return over the past 5 years, equivalent to a CAGR of 10.21% per annum. The stock was priced at ₹1,070.49 in Aug 2021 and has risen to ₹1,740.30 as of 06 Aug 2026. An investment of ₹1,00,000 in Ipca Laboratories Ltd five years ago would be worth ₹1,62,570.00 today.
Yes,Ipca Laboratories Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 18.00 per share between FY2022 and FY2026, with the most recent dividend of ₹6.00 per share for May 26, with an ex-dividend date of 07 Aug 2026. At the current market price of ₹1,740.30, the trailing dividend yield of Ipca Laboratories Ltd stands at 6.00%.
Ipca Laboratories Ltd has delivered a return of 12.82% over the last 3 months. The stock was trading at ₹1,564.40 on 06 May 2026 and is currently at ₹1,740.30 as of 06 Aug 2026, reflecting a Gain of ₹175.90 per share over this period.
The intraday low for Ipca Laboratories Ltd on the NSE today was ₹1,682.50. The stock's 52-week low stands at ₹1,251.60, recorded on 24 Oct 2025. Today's low is 34.43% above the 52-week low, indicating the stock is trading well above its yearly lows.
